4//SEC Filing
Grauch Edward Rowland 4
Accession 0001213900-22-043424
CIK 0001000683other
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 4:26 PM ET
Size
6.7 KB
Accession
0001213900-22-043424
Insider Transaction Report
Form 4
Grauch Edward Rowland
Executive Vice President & COO
Transactions
- Award
Common Stock, par value $0.001
2022-07-29$0.13/sh+7,988$1,038→ 638,485 total - Award
Common Stock, par value $0.001
2022-07-29$0.13/sh+70,235$9,131→ 708,720 total
Footnotes (1)
- [F1]Pursuant to a Deferred Compensation Agreement between the reporting person and the issuer, on the date on which a portion of the reporting person's compensation has been deferred, the issuer accrued the number of shares indicated. The number of shares of common stock accrued represents the quotient of (i) the portion of compensation deferred divided by (ii) the fair market value per share of the issuer's common stock on the indicated date (equal to the closing price reported on the NYSE American on such date).
Documents
Issuer
BLONDER TONGUE LABORATORIES INC
CIK 0001000683
Entity typeother
Related Parties
1- filerCIK 0001757536
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 4:26 PM ET
- Size
- 6.7 KB